Brief communication: Technical modifications of the human agarose microdroplet leukocyte migration inhibition assay
dc.contributor.author | Weese, James L. | en_US |
dc.contributor.author | McCoy, James L. | en_US |
dc.contributor.author | Dean, Jack H. | en_US |
dc.contributor.author | Ortaldo, John R. | en_US |
dc.contributor.author | Burk, Kathleen R. | en_US |
dc.contributor.author | Herberman, Ronald B. | en_US |
dc.date.accessioned | 2006-04-07T16:57:32Z | |
dc.date.available | 2006-04-07T16:57:32Z | |
dc.date.issued | 1978-12 | en_US |
dc.identifier.citation | Weese, James L., McCoy, James L., Dean, Jack H., Ortaldo, John R., Burk, Kathleen R., Herberman, Ronald B. (1978/12)."Brief communication: Technical modifications of the human agarose microdroplet leukocyte migration inhibition assay." Journal of Immunological Methods 24(3-4): 363-370. <http://hdl.handle.net/2027.42/22477> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T2Y-476KY7V-2RR/2/18d2b56e89a073cf530b53ba1699e99f | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/22477 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=722101&dopt=citation | en_US |
dc.description.abstract | Direct leukocyte migration inhibition assays using the capillary tube technique can be used to demonstrate cell-mediated immunity in vitro. Unfortunately, the cumbersome nature of this technique makes it time consuming and difficult to perform. Similar results have been obtained using the direct agarose microdroplet leukocyte migration inhibition assay. In this paper, modifications of the agarose technique are outlined which insure standardization of droplets and ease of performance of the assay. Additionally a technique is described to reduce the time required for calculation of results. | en_US |
dc.format.extent | 377259 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Brief communication: Technical modifications of the human agarose microdroplet leukocyte migration inhibition assay | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, MD 20014, USA: Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI 48104, USA | en_US |
dc.contributor.affiliationother | Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, MD 20014, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Litton Bionetics Research Laboratories, Kensington, MD 20975, USA | en_US |
dc.contributor.affiliationother | Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, MD 20014, USA | en_US |
dc.contributor.affiliationother | Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, MD 20014, USA | en_US |
dc.contributor.affiliationother | Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, MD 20014, USA | en_US |
dc.identifier.pmid | 722101 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/22477/1/0000018.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0022-1759(78)90139-4 | en_US |
dc.identifier.source | Journal of Immunological Methods | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.